- Odyssey, on second try, snags $279M in an IPO<figure><div><img src="https://imgproxy.divecdn.com/szYDL8kkQd6XaSVgvjJPYl2j0snveijWs_0sZ-B522Y/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xNDYyODUzODA3LmpwZ…BioPharma Dive · 2mo ago↗ source
- Sarepta tumbles as its gene therapy sales decline further<figure><div><img src="https://imgproxy.divecdn.com/XaTqfcte0RAZt6-RIcgWQ5i2KmL-mKKasPXR8xjfQW8/g:nowe:0:858/c:4256:2405/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9TYXJlcHRhX0Jvc…BioPharma Dive · 2mo ago↗ source
- Angelini to buy Catalyst in $4B play for rare neuro drugs<figure><div><img src="https://imgproxy.divecdn.com/4_eQ3BQP0sHe3AjR5s7bySznoaDhyqMpmhkmNubOdkU/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xNDQwMTY4MDMyXzEua…